Smithwills05 Jun, 2023Business
The global multiple myeloma drugs market size reached US$ 21.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 29.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.3% during 2023-2028. The rising incidences of multiple myeloma represent the primary factor driving the market growth.
The Win City
Martinsen Mccaffrey
Lyng Sivertsen
Nash French
Baird Klavsen
Business Manager
3355bet
Nedergaard Mclaughlin
We88
Luna Godfrey